Skip to content

Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young Adults

Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07547176
Acronym
BURGER
Enrollment
20
Registered
2026-04-23
Start date
2025-11-01
Completion date
2027-03-01
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Metabolism

Brief summary

The purpose of this study is to assess the amino acid oxidation dose-response relationship of ingested whole-food protein in healthy adults. In a randomized, crossover design, 20 young, healthy adult males and females aged 18-35 years, will consume a dinner consisting of 0.32, 0.74, and 1.32 g protein・kg BM-1 (corresponding to 1, 2, and 4 minced beef patties, respectively) during 3 separate experimental trials.The main study endpoint is the amino acid oxidation of ingested protein over a 24-h period.

Interventions

DIETARY_SUPPLEMENTFood proteins

Dinner meal consisting of minced beef protein.

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Within-subject, randomized, crossover design

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 18-35 years * BMI between 18.5-30 kg/m2 * Healthy, recreationally active (exercise at least once per two weeks and a maximum of four days per week) * No physical limitations (i.e., able to perform all activities associated with daily living independently)

Exclusion criteria

* Smoking * Vegan, vegetarian, or does not consume beef protein * Diagnosed musculoskeletal disorders * Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications) * Chronic use of gastric acid-suppressing medication or anti-coagulants * Unstable weight over the last three months * Diagnosed GI tract disorders or diseases * Blood donation in the past 2 months * Females: pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Amino acid oxidation of ingested proteinOver the 24 hour timeframe following protein ingestionAmino acid oxidation; compared between interventions to determine the dose-response relationship of amino acid oxidation to ingested whole-food protein.

Secondary

MeasureTime frameDescription
Plasma amino acid response of ingested proteinOver the 24 hour timeframe following protein ingestionPlasma amino acid response; comparison between interventions to determine the plasma amino acid response to different amounts of ingested whole-food protein.

Countries

Netherlands

Contacts

CONTACTJulia M Malowany, MSc
julia.malowany@maastrichtuniversity.nl+31 43 388 1617
CONTACTJorn Trommelen, PhD
jorn.trommelen@maastrichtuniversity.nl+31 43 388 1617
PRINCIPAL_INVESTIGATORLuc JC van Loon, PhD

Maastricht University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026